Relative Placement of Benefit and Risk Information in Direct-to-Consumer Advertisements of Prescription Drugs on the World Wide Web

Proceedings of the Human Factors and Ergonomics Society

Volumn , Issue , 2001, Pages 1196-1200

  Hicks, Kevin E ^a   Vigilante Jr , William J ^a   Wogalter, Michael S ^a  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APPROXIMATION THEORY; CORRELATION METHODS; DATA PROCESSING; DRUG PRODUCTS; MARKETING; WEBSITES;

DIRECT-TO-CONSUMER (DTC); NETSCAPE NAVIGATORS; RISK INFORMATION;

INFORMATION TECHNOLOGY;

EID: 0442295328     PISSN: 10711813     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.1177/154193120104501509     Document Type: Conference Paper

References (6)

1. Center for Drug Evaluation and Research (CDER) (2000). Attitudes and behaviors associated with direct-to-consumers (DTC) promotion of prescription drugs. FDA: Office of Medical Policy, Division of Drug Marketing, Advertising and Communications.
2. Food and Drug Administration (1999). Prescription Drug Advertisements (Federal Register, Title 21 Vol. 4, Parts 200-299). Washington, DC: U. S. Government Printing Office.
3. rd Ed). Montvale, NJ: Medical Economics Company, Inc.
4. Vigilante, W. J., Jr. (2001). Direct-to-Consumer (DTC) Advertising of Prescription Medications on the World Wide Web: Assessing the Communication of Risk and Benefits. In Proceedings of the Human Factors and Ergnomics Society 45th Annual Meeting. Santa Monica, CA: Human Factors and Ergonomics Society.
5. Wilkes, M. S., Bell, R. A. and Kravitz, R.L. (2000); Direct-to-consumer prescription drug advertising: trends, impact, and implications. Health Affairs, 19, 110-128.
6. rd Annual meeting (pp. 515-519). Santa Monica, CA: Human Factors and Ergonomics Society.